Selective Toxicity and Angiogenic Inhibition by Euglenophycin: A Role in Cancer Therapy?

Cancer Biology & Treatment
doi 10.24966/cbt-7546/100008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Herald Scholarly Open Access

Related search

Endothelial Cell Killing by TAK1 Inhibition: A Novel Anti-Angiogenic Strategy in Cancer Therapy

Developmental Cell
BiochemistryDevelopmental BiologyGeneticsCell BiologyMolecular Biology
2019English

Toxicity of SO2and NOx: Selective Inhibition of Blue-Green Algae by Bisulfite and Nitrite

Journal of the Air Pollution Control Association
1977English

Selective Autophagy in Cancer Development and Therapy

Cancer Research
Cancer ResearchOncology
2010English

Complement Inhibition in Cancer Therapy

Seminars in Immunology
AllergyImmunology
2013English

Inhibition of Progestin-Induced VEGF in Mammary Cancer by Curcumin and 2-Methoxy Estradiol and Their Potential Role as Anti-Angiogenic & Chemopreventive Compounds

English

Alginate Hydrogel Improves Anti-Angiogenic Bevacizumab Activity in Cancer Therapy

European Journal of Pharmaceutics and Biopharmaceutics
MedicineBiotechnologyPharmaceutical Science
2017English

Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention and Cancer Therapy

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
2006English

Selective Toxicity by HDAC3 in Neurons: Regulation by Akt and GSK3

Journal of Neuroscience
Neuroscience
2011English

Newly Developed Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy